White label – Pompe disease - ClinicalTrials.eu

Study of MK-2870 and Chemotherapy for Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Not recruiting

2 1
Investigated Diseases:
- Systemic scleroderma
Investigated Drugs:
- Fipaxalparant
+3
Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated Drugs:
- Riliprubart
Study on Benralizumab for Patients with Severe Asthma

Not recruiting

3 1 1 1
Investigated Drugs:
- Benralizumab
Study on Nanatinostat and Valganciclovir for Patients with Epstein-Barr Virus-Positive Relapsed or Refractory Lymphomas

Not recruiting

2 1 1 1
Investigated Diseases:
- Epstein-Barr virus associated lymphoma
Investigated Drugs:
Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

Not recruiting

1 1 1 1
Investigated Drugs:
Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Not recruiting

3 1 1 1
Investigated Diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated Drugs:
+3
Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

Not recruiting

2 1 1
Investigated Drugs:
- Givinostat
Study on the Long-Term Safety of Bepranemab for Adults with Progressive Supranuclear Palsy

Not recruiting

1 1 1
Investigated Diseases:
- Progressive supranuclear palsy
Investigated Drugs:
- Bepranemab
Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies